Stay Informed on Corporate Sustainability

Author: Archie Villaflores

IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, has assumed direct commercial and distribution responsibility for bladder therapy ialuril® across the UK and Ireland

Author: Archie Villaflores

Ireland’s biopharma sector grew pharmaceutical exports 29% in 2024 while cutting electricity-related carbon dioxide emissions by 30.5%. BioPharmaChem Ireland’s Responsible Care Report 2026 proves that high-value manufacturing and environmental stewardship can advance together.

Author: Archie Villaflores

Casting back to the Pharma Industry Awards 2025, Bristol Myers Squibb Ireland claimed last year the Communications Award for a recruitment campaign that put employees at the centre of the narrative, delivering a message of authenticity and creativity that resonated deeply with its target audience and produced measurable results. The win set a new standard for pharmaceutical communications in Ireland, demonstrating the level of strategic clarity, creative conviction, and evidenced impact that entrants will look to match on the 2026 awards cycle.

Author: Archie Villaflores

Canadian biopharmaceutical company Avicanna has appointed Ozgur Kilic to its board of directors, following the resignation of John McVicar, as the cannabinoid-focused firm targets further expansion in the United States and international markets.

Author: Archie Villaflores

US technology and manufacturing firm Eastman Kodak is expanding into pharmaceutical manufacturing by producing key starting materials domestically, aiming to strengthen supply chain resilience and compliance standards across the sector.

Author: Archie Villaflores

London-based GSK and Osaka-based Shionogi have completed the replacement of Pfizer's stake in HIV-focused joint venture ViiV Healthcare, with Shionogi acquiring a 22% interest in the London-based pharmaceutical venture.

Author: Archie Villaflores

BioPharmaChem Ireland has elected Tim Shanahan, VP External Manufacturing Operations at Ipsen, as its new chairperson, succeeding outgoing chair Joyce Fitzharris of SK pharmteco, as reported by Business Eye.c

Author: Archie Villaflores

Irish biotech firm ArrayPatch has acquired intellectual property from Vitropep for peptide delivery via dissolving microneedle patches, expanding its drug delivery platform to address therapeutic areas including diabetes, obesity, oncology, and cardiovascular disease.

Author: Archie Villaflores

Ireland’s 2026 medicines framework introduces a value maintenance realignment to address the pricing root causes of essential medicine shortages. The Medicines for Ireland agreement acknowledges that below-cost reimbursement drives supplier market exit, threatening continuity of patient care.

Author: Archie Villaflores

Revisiting a standout moment from last year, MSD Ireland claimed both the Operational Excellence Award and the Diversity, Equality & Inclusion Strategy of the Year at the Pharma Industry Awards 2025, recognised for a combination of transformative operational performance and deeply embedded inclusive leadership across all Irish sites. The double win reflects the breadth of ambition and measurable impact the Pharma Industry Awards reward, setting a compelling standard of integrated excellence that organisations across Ireland's pharmaceutical sector will look to match for the 2026 cycle.